-
KTTA Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Pasithea Therapeutics (KTTA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 9.36 mm | 9.36 mm | 9.36 mm | 9.36 mm | 9.36 mm | 9.36 mm |
Cash burn (monthly) | (no burn) | 851.96 k | 1.00 mm | 1.34 mm | 1.04 mm | 1.23 mm |
Cash used (since last report) | n/a | 3.17 mm | 3.73 mm | 5.01 mm | 3.87 mm | 4.58 mm |
Cash remaining | n/a | 6.19 mm | 5.63 mm | 4.35 mm | 5.49 mm | 4.78 mm |
Runway (months of cash) | n/a | 7.3 | 5.6 | 3.2 | 5.3 | 3.9 |
13F holders | Current |
---|---|
Total holders | 4 |
Opened positions | 1 |
Closed positions | 6 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 10.37 mm |
Total shares | 5.27 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Paul B Manning | 3.41 mm | $3.30 mm |
IOI Ionic Ventures | 870.27 k | $1.54 mm |
Alpha Capital Anstalt | 715.00 k | $1.27 mm |
Warberg Asset Management | 278.68 k | $4.26 mm |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Jun 24 | Novak Alfred J | Common Stock | Grant | Acquire A | No | No | 5.62 | 2,750 | 15.46 k | 3,500 |
12 Jun 24 | Novak Alfred J | Common Stock | Grant | Acquire A | No | No | 5.61 | 750 | 4.21 k | 750 |
1 Mar 24 | Lawrence Steinman | Stock Option Common Stock | Grant | Acquire A | No | No | 8.34 | 7,500 | 62.55 k | 7,500 |
1 Mar 24 | Schneiderman Daniel H | Stock Option Common Stock | Grant | Acquire A | No | No | 8.34 | 5,927 | 49.43 k | 5,927 |
1 Mar 24 | Schneiderman Daniel H | Stock Option Common Stock | Grant | Acquire A | No | No | 8.34 | 10,000 | 83.40 k | 10,000 |
1 Mar 24 | Novak Alfred J | Stock Option Common Stock | Grant | Acquire A | No | No | 8.34 | 5,000 | 41.70 k | 5,000 |
1 Mar 24 | Tiago Marques | Stock Option Common Stock | Grant | Acquire A | No | No | 8.34 | 11,669 | 97.32 k | 11,669 |
1 Mar 24 | Tiago Marques | Stock Option Common Stock | Grant | Acquire A | No | No | 8.34 | 15,000 | 125.10 k | 15,000 |